MAPT and tauopathy: Interestingly, CTSD KO mice develop significant tauopathy by about three weeks of age, characterized by the accumulation of hyperphosphorylated tau, which is more severe than in other mouse models of tauopathy, such as JNPL3, without the need for overexpression of human tau with disease-associated mutations 26 (Table 1).